Search

Author/Creator Mee, Matthew

1. Dose‐dense chemotherapy for untreated poor‐prognosis and relapsed germ‐cell tumours: an 18‐year experience with GAMEC chemotherapy. (4th May 2020)

Authors:
Shamash, Jonathan; Mee, Matthew; Sarker, Shah‐Jalal; Wilson, Peter; Ansell, Wendy; Greenwood, Michelle; Berney, Dan; Alifrangis, Constantine
Journal:
BJU international
Issue:
Volume 125:Number 6(2020)
Page Start:
843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search